The Fund supports several networks of state health policymakers to help identify, inspire, and inform policy leaders.
The Fund identifies and shares policy ideas and analysis on topics important to state health policymakers, particularly on issues related to state leadership, primary care, aging, and total costs of care.
Keep up with news and updates from the Milbank Memorial Fund. And read the latest blogs from our thought leaders, including Fund President Christopher F. Koller.
The Fund publishes The Milbank Quarterly, as well as reports, issues briefs, and case studies on topics important to health policy leaders.
The Milbank Memorial Fund is an endowed operating foundation that publishes The Milbank Quarterly, commissions projects, and convenes state health policy decision makers on issues they identify as important to population health.
Forced migration—whether from persecution, climate change, or poverty—is undermining key global health goals, including universal health coverage and health equity. In May, the World Health Organization (WHO) adopted a five-year Global Action Plan (GAP) to Promote the Health of Refugees and Migrants. But in a new Early View Opinion in The Milbank Quarterly, Lawrence O. Gostin, University Professor in Global Health Law at Georgetown University, says that the plan may stumble because of WHO’s insufficient resources and weak political influence. More
The Centers for Medicare and Medicaid Services recently unveiled its “Primary Cares Initiative,” which it describes as its biggest effort to replace fee-for-service payment and transform primary care delivery More
There has been a significant focus on patient safety issues over the past two decades. This began with the release of To Err is Human in late 1999,1… More
A Washington Post article recently stated that there was no evidence that “thousands of women died every year in the United States from illegal abortions” before the 1973 Roe v. Wade ruling, as Planned Parenthood President Dr. Leana Wen had asserted. More
Among the opioid epidemic’s most wrenching harms are the increased numbers of parents who struggle to care for their children. This year, more than… More
The 2013 U.S. Supreme Court decision in Association for Molecular Pathology v. Myriad Genetics, Inc. was seen by many as a triumph for public health. The opinion found human genes were ineligible for patent protection, allowing many companies to offer single-gene diagnostic tests, like those for breast and ovarian cancer risk, which were at issue in Myriad Genetics. More
Get the Latest from the Milbank Memorial Fund
The Milbank Quarterly’s multidisciplinary approach and commitment to applying the best empirical research to practical policymaking offers in-depth assessments of the social, economic, historical, legal, and ethical dimensions of health and health care policy.